(1)
Goldberg, M. S.; Siegel, J. J.; Ahmed, K.; Kurley, S. J.; Farberg, A. S. A Prospective Clinical Utility Study Demonstrates That Physicians Use the 40-Gene Expression Profile (40-GEP) to Guide Clinical Management Decisions for Medicare-Eligible Patients With Cutaneous Squamous Cell Carcinoma (cSCC). J of Skin 2022, 6, s95.